How do you manage injection site reactions in patients on subcutaneous biologics such as TNF inhibitors?

Injection site reactions are not infrequent, though the majority are self-limited and do not result in discontinuation of the drug. For those uncommon few individuals whose skin lesions are more prominent and symptoms (such as pain and itch) are aggravating, I first review that they are properly sel...

Additional approach is to apply ice.